BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18462441)

  • 1. Widespread granuloma annulare and Hodgkin's disease.
    Dadban A; Slama B; Azzedine A; Lepeu G
    Clin Exp Dermatol; 2008 Jul; 33(4):465-8. PubMed ID: 18462441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granuloma annulare on herpes zoster scars in a Hodgkin's disease patient following autologous peripheral stem cell transplantation.
    Sanli HE; Koçyiğit P; Arica E; Kurtyüksel M; Heper AO; Ozcan M
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):314-7. PubMed ID: 16503895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic granulomatous dermatitis in a patient with Hodgkin's disease: a diagnostic pitfall.
    Tabata MM; Novoa RA; Martires KJ
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30100570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous granuloma annulare with Hodgkin's disease.
    Miyamoto T; Mihara M
    J Dermatol; 1996 Jun; 23(6):405-7. PubMed ID: 8708153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized granuloma annulare and non-Hodgkin's lymphoma.
    Bassi A; Scarfi F; Galeone M; Arunachalam M; Difonzo E
    Acta Derm Venereol; 2013 Jul; 93(4):484-5. PubMed ID: 23250047
    [No Abstract]   [Full Text] [Related]  

  • 6. Granuloma annulare-like infiltrates with concomitant cutaneous involvement by B-cell non-Hodgkin's lymphoma: report of a case.
    Fullen DR; Jacobson SN; Valdez R; Novice FM; Lowe L
    Am J Dermatopathol; 2003 Feb; 25(1):57-61. PubMed ID: 12544102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized granuloma annulare post autologous bone marrow transplantation in a Hodgkin's disease patient.
    Nevo S; Drakos P; Goldenhersh MA; Zlotogorski A; Or R; Naparstek E; Nagler A
    Bone Marrow Transplant; 1994 Oct; 14(4):631-3. PubMed ID: 7858539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granuloma annulare in patients with malignant lymphoma: clinicopathologic study of thirteen new cases.
    Barksdale SK; Perniciaro C; Halling KC; Strickler JG
    J Am Acad Dermatol; 1994 Jul; 31(1):42-8. PubMed ID: 8021370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
    Schiffman K; Buckner CD; Maziarz R; Maloney DG; Appelbaum FR; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger WI
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):261-6. PubMed ID: 9450921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granuloma annulare with prominent lymphoid infiltrates ("pseudolymphomatous" granuloma annulare).
    Cota C; Ferrara G; Cerroni L
    Am J Dermatopathol; 2012 May; 34(3):259-62. PubMed ID: 22207445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress and controversy in treatment of Hodgkin's disease].
    Robak T
    Acta Haematol Pol; 1995; 26(4):343-52. PubMed ID: 8571735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease.
    Anselmo AP; Cavalieri E; Meloni G; Alimena G; Cantonetti M; Maurizi Enrici R; Tosti ME; Falchetto Osti M; Gianfelici V; Mandelli F
    Haematologica; 2002 May; 87(5):507-11. PubMed ID: 12010664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
    Gutierrez-Delgado F; Holmberg L; Hooper H; Petersdorf S; Press O; Maziarz R; Maloney D; Chauncey T; Appelbaum F; Bensinger W
    Bone Marrow Transplant; 2003 Aug; 32(3):279-85. PubMed ID: 12858199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
    Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F
    Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy in Hodgkin's lymphoma.
    Mendler JH; Friedberg JW
    Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
    Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.